CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 443 filers reported holding CRISPR THERAPEUTICS AG in Q4 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5 | -16.7% | 100 | 0.0% | 0.00% | – |
| Q2 2023 | $6 | +20.0% | 100 | 0.0% | 0.00% | – |
| Q1 2023 | $5 | +25.0% | 100 | 0.0% | 0.00% | – |
| Q4 2022 | $4 | -99.9% | 100 | 0.0% | 0.00% | – |
| Q3 2022 | $7,000 | +16.7% | 100 | 0.0% | 0.00% | – |
| Q2 2022 | $6,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2022 | $6,000 | -25.0% | 100 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | -27.3% | 100 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $11,000 | -31.2% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $16,000 | -33.3% | 100 | -50.0% | 0.00% | 0.0% |
| Q1 2021 | $24,000 | +50.0% | 200 | -50.0% | 0.00% | 0.0% |
| Q3 2019 | $16,000 | -72.4% | 400 | -67.4% | 0.00% | -80.0% |
| Q2 2019 | $58,000 | +31.8% | 1,227 | 0.0% | 0.01% | +25.0% |
| Q1 2019 | $44,000 | -4.3% | 1,227 | -24.6% | 0.00% | -20.0% |
| Q4 2018 | $46,000 | +24.3% | 1,627 | +96.7% | 0.01% | +66.7% |
| Q3 2018 | $37,000 | +32.1% | 827 | +73.4% | 0.00% | 0.0% |
| Q2 2018 | $28,000 | +460.0% | 477 | +377.0% | 0.00% | +200.0% |
| Q1 2018 | $5,000 | +150.0% | 100 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |